vTv Therapeutics (VTVT) EPS (Basic) (2014 - 2026)
vTv Therapeutics (VTVT) posted EPS (Basic) of $1.94 for Q1 2026, up 329.51% sequentially from -$0.85 in Q4 2025, and up 351.42% YoY from $0.43 in Q1 2025.
vTv Therapeutics (VTVT) EPS (Basic) (2014 - 2026) Analysis & Trends
vTv Therapeutics has reported EPS (Basic) for 13 years, with the latest figure at $1.94 in Q1 2026.
- Quarterly EPS (Basic) rose 351.42% year-over-year to $1.94 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.18 (up 106.39% YoY) and the FY2025 annual result came in at -$3.2, changed 0.1% from the prior year.
- EPS (Basic) improved to $1.94 in Q1 2026 per VTVT's latest filing, from -$0.85 in the prior quarter.
- Over five years, EPS (Basic) peaked at $1.94 in Q1 2026 and troughed at -$4.19 in Q1 2022.
- A 5-year average of -$1.51 and a median of -$1.17 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2026: EPS (Basic) plunged 331.7% in 2022, then jumped 351.42% in 2026.
- Over 5 years, EPS (Basic) stood at -$2.53 in 2022, then jumped by 34.19% to -$1.67 in 2023, then soared by 62.25% to -$0.63 in 2024, then slumped by 34.57% to -$0.85 in 2025, then surged by 329.51% to $1.94 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $1.94, -$0.85, and -$1.08 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - | -1.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.05 |
| Mar 31, 2026 | 1.94 |
| Dec 31, 2025 | -0.85 |
| Sep 30, 2025 | -1.08 |
| Jun 30, 2025 | -0.92 |
| Mar 31, 2025 | -0.77 |
| Dec 31, 2024 | -0.63 |
| Sep 30, 2024 | -0.88 |
| Jun 30, 2024 | -0.81 |
| Mar 31, 2024 | -1.17 |
| Dec 31, 2023 | -1.67 |
| Sep 30, 2023 | -3.27 |
| Jun 30, 2023 | -2.76 |
| Mar 31, 2023 | -2.21 |
| Dec 31, 2022 | -2.53 |
| Sep 30, 2022 | -2.12 |
| Jun 30, 2022 | -1.79 |
| Mar 31, 2022 | -4.19 |
| Dec 31, 2021 | -4.64 |
| Sep 30, 2021 | -0.71 |